GRFS
Grifols, S.A.NASDAQHealthcare$8.24-0.12%ClosedMarket Cap: $6.97B
As of 2026-04-06
Valuation
P/E (TTM)
17.38
PEG
0.11
P/B
1.20
P/S
0.83
EV/EBITDA
10.16
DCF Value
$21.29
FCF Yield
12.5%
Div Yield
1.6%
Margins & Returns
Gross Margin
38.4%
Operating Margin
17.0%
Net Margin
5.3%
ROE
7.6%
ROA
4.0%
ROIC
5.7%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 2025 | $1.96B | 34.7% | $272.2M | $97.3M | $0.14 | — |
| FY 2025 | $7.23B | 35.7% | $1.19B | $386.1M | $0.57 | $0.14 |
| Q3 2025 | $1.87B | 40.3% | $383.3M | $127.0M | $0.19 | $0.14 |
| Q2 2025 | $1.89B | 39.3% | $348.9M | $117.1M | $0.17 | — |
| Q1 2025 | $1.79B | 39.5% | $268.9M | $59.7M | $0.09 | — |
| Q4 2024 | $1.98B | 38.8% | $371.9M | $69.0M | $0.10 | — |
| FY 2024 | $7.21B | 38.7% | $1.19B | $156.9M | $0.23 | — |
| Q3 2024 | $1.79B | 40.5% | $317.0M | $51.7M | $0.08 | — |
| Q2 2024 | $1.82B | 36.9% | $299.3M | $14.8M | $0.02 | — |
| Q1 2024 | $1.63B | 39.9% | $203.8M | $21.4M | $0.03 | — |
| Q4 2023 | $1.77B | 39.0% | $254.8M | $56.0M | $0.08 | — |
| FY 2023 | $6.59B | 37.7% | $782.3M | $42.3M | $0.09 | — |